A recent Free News article discussed the latest mRNA development from Moderna, maker of one of the main COVID-19 vaccines. Apparently the company has two experimental HIV vaccines in work that are expected to begin clinical trials before the end of the year. The vaccines, Moderna mRNA-1644 and mRNA-1644v2-Core, have both passed phase I testing.
Moderna Nears Trials for HIV Vaccine
After the success of its COVID-19 vaccine, Moderna looks for lightning to strike twice.
Aug 19, 2021